Newsletter-21

477 LEGAL DEVELOPMENTS • The Board authorized the acquisition of St. Jude Medical Inc. by Abbott Laboratories. (03.11.2016, 16-36/611-273) • The Board authorized the merger of Akiş Gayrimenkul Yatırım Ortaklığı A.Ş. and Saf Gayrimenkul Yatırım Ortaklığı A.Ş. in Akiş Gayrimenkul Yatırım Ortaklığı A.Ş.’s structure through the acquisition of Saf Gayrimenkul Yatırım Ortaklığı A.Ş. with all of its assets and liabilities as a whole by Akiş Gayrimenkul Yatırım Ortaklığı A.Ş. (03.11.2016, 16-36/617-277) • The Board authorized the acquisition of equipment of EİS Eczacıbaşı İlaç, Sınai ve Finansal Yatırımlar San. ve Tic. A.Ş. and “IV Serum Product Assets” of Eczacıbaşı-Baxter Hastane Ürünleri San. ve Tic. A.Ş. by Koçak Farma İlaç ve Kimya San. A.Ş. (03.11.2016, 16-36/625-278) • The Board authorized the acquisition of 100% shares of Thrace Basin Natural Gas Corporation (Turkey) by Valeura Energy B.V. (Netherlands). (16.11.2016, 16-39/631-280) • The Board authorized the merger of International Petroleum Investment Company with Mubadala Development Com- pany P.J.S.C. (24.11.2016, 16-41/ 663- 297) • The Board authorized establishment of joint control on Al- legro Sp. Zo and Ceneo Sp. Zo by Permira Advisers LLP and Cinven LLP Capital Management (VI). (24.11.2016, 16-41/665-298) • The Board authorized the establishment of a joint venture company by TDK Corporation and Toshiba Corporation. (24.11.2016, 16-41/669-301) • The Board authorized the acquisition of Wuhan Iron and Steel (Group) Corporation by Baosteel Group Corporation. (24.11.2016, 16-41/ 671-302) • The Board decided that the transfer of the shares of Ateş Çe- lik İnşaat Taahhüt Proje Mühendislik Sanayi ve Ticaret A.Ş., owned by Erkan Güldoğan to Ercan Güldoğan and Mahmut